PXS — Provexis Balance Sheet
0.000.00%
Last trade - 00:00
- £13.58m
- £12.73m
- £0.39m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.326 | 0.291 | 1.08 | 0.864 | 0.379 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.091 | 0.167 | 0.05 | 0.117 | 0.122 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.462 | 0.469 | 1.29 | 1.13 | 0.846 |
Total Assets | 0.462 | 0.469 | 1.29 | 1.13 | 0.846 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.123 | 0.15 | 0.151 | 0.158 | 0.188 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | -0.354 | -0.346 | -0.363 | -0.372 | -0.344 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.816 | 0.814 | 1.66 | 1.5 | 1.19 |
Total Liabilities & Shareholders' Equity | 0.462 | 0.469 | 1.29 | 1.13 | 0.846 |
Total Common Shares Outstanding |